Toxicity rates of cART modification per 100 person years for individual antiretroviral regimen.

Crude rate of first major modification to ART and average per patient per year HIV monitoring (CD4 cell count and HIV RNA-VL) by country.

Stephen Wright (425794)
Mark A. Boyd (282416)
Evy Yunihastuti (428215)
Matthew Law (36008)
Thira Sirisanthana (199610)
Jennifer Hoy (315568)
Sanjay Pujari (428216)
Man Po Lee (428217)
Kathy Petoumenos (300180)

June 2013

Crude rate of first major modification to ART and average per patient per year HIV monitoring (CD...

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

Torres, Thiago Silva
Cardoso, Sandra Wagner
Velasque, Luciane S.
Veloso, Valdilea G.
Grinsztejn, Beatriz

February 2014

AbstractToxicity is the most frequently reported reason for modifying or discontinuing the first com...

Forest plot of mortality relative risks reported by 22 studies.

Heidi M. Soeters (470869)
Charles Poole (71733)
Monita R. Patel (470870)
Annelies Van Rie (36715)

October 2013

The relative risks correspond to the estimated effect of receiving vs. not receiving TB treatment...

Mihanović, Marta Perović
Haque, Najm S
Rutherford, George W
Zekan, Šime
Begovac, Josip

January 2013

BackgroundModifications to combination antiretroviral drug therapy (CART) regimens can occur for a n...

ORIGINAL INVESTIGATION Treatment Modification in Human Immunodeficiency Virus–Infected Individuals Starting Combination

November 2015

Background: Adverse effects of combination antiret-roviral therapy (CART) commonly result in treatme...

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008

Elzi, Luigia
Marzolini, Catia
Furrer, Hansjakob
Ledergerber, Bruno
Cavassini, Matthias
Hirschel, Bernard
Vernazza, Pietro
Bernasconi, Enos
Weber, Rainer
Battegay, Manuel
Swiss HIV Cohort Study,

January 2010

Adverse effects of combination antiretroviral therapy (CART) commonly result in treatment modificati...

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.

Elzi, L.
Marzolini, C.
Furrer, H.
Ledergerber, B.
Cavassini, M.
Hirschel, B.
Vernazza, P.
Bernasconi, E.
Weber, R.
Battegay, M.

January 2010

BACKGROUND: Adverse effects of combination antiretroviral therapy (CART) commonly result in treatmen...

Long-term exposure to combination antiretroviral therapy and risk of death from specific causes : no evidence for any previously unidentified increased risk due to antiretroviral therapy

J.D. Kowalska
J. Reekie
A. Mocroft
P. Reiss
B. Ledergerber
J. Gatell
A. D'Arminio Monforte
A. Phillips
J.D. Lundgren
O. Kirk
the EuroSIDA study group

January 2012

BACKGROUND: Despite the known substantial benefits of combination antiretroviral therapy (cART), cum...

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

Torres, Thiago Silva
Cardoso, Sandra Wagner
Velasque, Luciane de Souza
Santos, Valdiléa Gonçalves Veloso dos
Grinsztejn, Beatriz Gilda Jegerhorn

January 2014

Toxicity is the most frequently reported reason for modifying or discontinuing the first com-bined a...

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while on cART: event rates per 1,000 y of suppressed viral load (number of events) over time for the primary outcome (a first new AIDS event or death).

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (614233)

March 2012

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while o...

Frequencies of specific toxicities and treatment switches among Ghanaian cohort on long-term cART.

Fred Stephen Sarfo (139071)
Maame Anima Sarfo (550970)
Betty Norman (550971)
Richard Phillips (205457)
George Bedu-Addo (274645)
David Chadwick (300132)

October 2014

# This refers to the number of patients switching treatment due to specific toxicity specified on...

Decreasing rate of multiple treatment modifications among individuals who initiated antiretroviral therapy in 1997-2009 in the Danish HIV cohort study

Helleberg, Marie
Kronborg, Gitte
Larsen, Carsten S.
Pedersen, Gitte
Pedersen, Court
Nielsen, Lars
Laursen, Alex L.
Obel, Niels
Gerstoft, Jan

May 2013

Background: We hypothesized that rates and reasons for treatment modifications have changed since th...

Hazard ratio (HR) k of treatment interruption by duration of HIV infection (as time between HIV seroconversion and cART initiation) and CD4 count at cART initiation.

Sara Lodi (462540)
Andrew Phillips (201315)
Sarah Fidler (76851)
David Hawkins (462541)
Richard Gilson (125405)
Ken McLean (462542)
Martin Fisher (300134)
Frank Post (462543)
Anne M. Johnson (282427)
Louise Walker-Nthenda (462544)
David Dunn (37023)
Kholoud Porter (252703)

September 2013

Hazard ratio (HR) k of treatment interruption by duration of HIV infection (as time between HIV s...

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

Stecher, Melanie
Schommers, Philipp
Kollan, Christian
Stoll, Matthias
Kuhlendahl, Frieder
Stellbrink, Hans‑Jürgen
Wasmuth, Jan‑Christian
Stephan, Christoph
Hamacher, Laura
Lehmann, Clara
Boesecke, Christoph
Bogner, Johannes
Esser, Stefan
Fritzsche, Carlos
Haberl, Annette
Hofmann, Christian
Jensen, Björn
Schwarze‑Zander, Carolynne
Platten, Martin
Fätkenheuer, Gerd
Schmidt, Daniel
Gunsenheimer‑Bartmeyer, Barbara
Vehreschild, Jörg Janne

January 2020

Objective: Combination antiretroviral therapy (cART) has markedly increased survival and quality of ...

Quantifying the Decrement in Utility from Perceived Side Effects of Combination Antiretroviral Therapies in Patients with HIV

Braithwaite, R. Scott
Goulet, Joseph
Kudel, Ian
Tsevat, Joel
Justice, Amy C.

October 2008

AbstractBackgroundThe decrement in utility attributable to side effects from combination antiretrovi...

Crude rate of first major modification to ART and average per patient per year HIV monitoring (CD4 cell count and HIV RNA-VL) by country.

Stephen Wright (425794)
Mark A. Boyd (282416)
Evy Yunihastuti (428215)
Matthew Law (36008)
Thira Sirisanthana (199610)
Jennifer Hoy (315568)
Sanjay Pujari (428216)
Man Po Lee (428217)
Kathy Petoumenos (300180)

June 2013

Crude rate of first major modification to ART and average per patient per year HIV monitoring (CD...

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

Torres, Thiago Silva
Cardoso, Sandra Wagner
Velasque, Luciane S.
Veloso, Valdilea G.
Grinsztejn, Beatriz

February 2014

AbstractToxicity is the most frequently reported reason for modifying or discontinuing the first com...

Forest plot of mortality relative risks reported by 22 studies.

Heidi M. Soeters (470869)
Charles Poole (71733)
Monita R. Patel (470870)
Annelies Van Rie (36715)

October 2013

The relative risks correspond to the estimated effect of receiving vs. not receiving TB treatment...

Mihanović, Marta Perović
Haque, Najm S
Rutherford, George W
Zekan, Šime
Begovac, Josip

January 2013

BackgroundModifications to combination antiretroviral drug therapy (CART) regimens can occur for a n...

ORIGINAL INVESTIGATION Treatment Modification in Human Immunodeficiency Virus–Infected Individuals Starting Combination

November 2015

Background: Adverse effects of combination antiret-roviral therapy (CART) commonly result in treatme...

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008

Elzi, Luigia
Marzolini, Catia
Furrer, Hansjakob
Ledergerber, Bruno
Cavassini, Matthias
Hirschel, Bernard
Vernazza, Pietro
Bernasconi, Enos
Weber, Rainer
Battegay, Manuel
Swiss HIV Cohort Study,

January 2010

Adverse effects of combination antiretroviral therapy (CART) commonly result in treatment modificati...

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.

Elzi, L.
Marzolini, C.
Furrer, H.
Ledergerber, B.
Cavassini, M.
Hirschel, B.
Vernazza, P.
Bernasconi, E.
Weber, R.
Battegay, M.

January 2010

BACKGROUND: Adverse effects of combination antiretroviral therapy (CART) commonly result in treatmen...

Long-term exposure to combination antiretroviral therapy and risk of death from specific causes : no evidence for any previously unidentified increased risk due to antiretroviral therapy

J.D. Kowalska
J. Reekie
A. Mocroft
P. Reiss
B. Ledergerber
J. Gatell
A. D'Arminio Monforte
A. Phillips
J.D. Lundgren
O. Kirk
the EuroSIDA study group

January 2012

BACKGROUND: Despite the known substantial benefits of combination antiretroviral therapy (cART), cum...

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

Torres, Thiago Silva
Cardoso, Sandra Wagner
Velasque, Luciane de Souza
Santos, Valdiléa Gonçalves Veloso dos
Grinsztejn, Beatriz Gilda Jegerhorn

January 2014

Toxicity is the most frequently reported reason for modifying or discontinuing the first com-bined a...

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while on cART: event rates per 1,000 y of suppressed viral load (number of events) over time for the primary outcome (a first new AIDS event or death).

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (614233)

March 2012

Event rates in CD4 strata among the 75,336 patients with at least one suppression episode while o...

Frequencies of specific toxicities and treatment switches among Ghanaian cohort on long-term cART.

Fred Stephen Sarfo (139071)
Maame Anima Sarfo (550970)
Betty Norman (550971)
Richard Phillips (205457)
George Bedu-Addo (274645)
David Chadwick (300132)

October 2014

# This refers to the number of patients switching treatment due to specific toxicity specified on...

Decreasing rate of multiple treatment modifications among individuals who initiated antiretroviral therapy in 1997-2009 in the Danish HIV cohort study

Helleberg, Marie
Kronborg, Gitte
Larsen, Carsten S.
Pedersen, Gitte
Pedersen, Court
Nielsen, Lars
Laursen, Alex L.
Obel, Niels
Gerstoft, Jan

May 2013

Background: We hypothesized that rates and reasons for treatment modifications have changed since th...

Hazard ratio (HR) k of treatment interruption by duration of HIV infection (as time between HIV seroconversion and cART initiation) and CD4 count at cART initiation.

Sara Lodi (462540)
Andrew Phillips (201315)
Sarah Fidler (76851)
David Hawkins (462541)
Richard Gilson (125405)
Ken McLean (462542)
Martin Fisher (300134)
Frank Post (462543)
Anne M. Johnson (282427)
Louise Walker-Nthenda (462544)
David Dunn (37023)
Kholoud Porter (252703)

September 2013

Hazard ratio (HR) k of treatment interruption by duration of HIV infection (as time between HIV s...

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

Stecher, Melanie
Schommers, Philipp
Kollan, Christian
Stoll, Matthias
Kuhlendahl, Frieder
Stellbrink, Hans‑Jürgen
Wasmuth, Jan‑Christian
Stephan, Christoph
Hamacher, Laura
Lehmann, Clara
Boesecke, Christoph
Bogner, Johannes
Esser, Stefan
Fritzsche, Carlos
Haberl, Annette
Hofmann, Christian
Jensen, Björn
Schwarze‑Zander, Carolynne
Platten, Martin
Fätkenheuer, Gerd
Schmidt, Daniel
Gunsenheimer‑Bartmeyer, Barbara
Vehreschild, Jörg Janne

January 2020

Objective: Combination antiretroviral therapy (cART) has markedly increased survival and quality of ...

Quantifying the Decrement in Utility from Perceived Side Effects of Combination Antiretroviral Therapies in Patients with HIV

Braithwaite, R. Scott
Goulet, Joseph
Kudel, Ian
Tsevat, Joel
Justice, Amy C.

October 2008

AbstractBackgroundThe decrement in utility attributable to side effects from combination antiretrovi...

Crude rate of first major modification to ART and average per patient per year HIV monitoring (CD4 cell count and HIV RNA-VL) by country.

Stephen Wright (425794)
Mark A. Boyd (282416)
Evy Yunihastuti (428215)
Matthew Law (36008)
Thira Sirisanthana (199610)
Jennifer Hoy (315568)
Sanjay Pujari (428216)
Man Po Lee (428217)
Kathy Petoumenos (300180)

June 2013

Crude rate of first major modification to ART and average per patient per year HIV monitoring (CD...

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

Torres, Thiago Silva
Cardoso, Sandra Wagner
Velasque, Luciane S.
Veloso, Valdilea G.
Grinsztejn, Beatriz

February 2014

AbstractToxicity is the most frequently reported reason for modifying or discontinuing the first com...

Forest plot of mortality relative risks reported by 22 studies.

Heidi M. Soeters (470869)
Charles Poole (71733)
Monita R. Patel (470870)
Annelies Van Rie (36715)

October 2013

The relative risks correspond to the estimated effect of receiving vs. not receiving TB treatment...

Toxicity rates of cART modification per 100 person years for individual antiretroviral regimen.

Abstract

Extracted data

Toxicity rates of cART modification per 100 person years for individual antiretroviral regimen.

Abstract

Extracted data

Related items

Related items